12.10.2021 To the attention of interested persons Questions and answers on end of rolling review for CureVac’s COVID-19 vaccine (CVnCoV) […]

14.10.2021 To the attention of interested persons EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) download document …

12.10.2021 To the attention of interested persons EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG […]

11.10.2021 To the attention of interested persons EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment […]

07.10.2021 To the attention of interested persons Additional manufacturing site for COVID-19 Vaccine Janssen download document …

04.10.2021 To the attention of interested persons Comirnaty and Spikevax: EMA recommendations on extra doses and boosters download document …

04.10.2021 To the attention of interested persons EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with […]

01.10.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 download […]

01.10.2021 To the attention of interested persons EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines download document […]

27.09.2021 To the attention of interested persons EMA evaluating data on booster dose of COVID-19 vaccine Spikevax download document …